Baird Capital’s China Growth Equity team invests in smaller, high-potential companies located in China or with substantial operations and growth opportunities in China. We focus on the Healthcare, Technology & Services, and Products sectors.
With more than 15 experienced investment and operating professionals across Asia, our team has a unique ability to drive value in Chinese companies on both a local and global basis. We take a hands-on approach to helping our portfolio companies grow, leveraging our operational resources and global relationship network to build market-leading companies in China.
We invest up to $10 million in private, entrepreneur-owned companies that meet our three basic investment criteria:
- Significant China Opportunity - Substantial existing operations in China and a large future growth opportunity
- Operates in one of our sectors of focus
- Opportunity to add operational and strategic value through our global resources
In addition, our extensive global resources allow us to bring significant value to smaller Chinese companies.